STERIS plc
STERIS plc provides products and services used to prevent infection and support sterile processing across healthcare and life sciences settings. Its portfolio spans consumables, capital equipment, maintenance and repair services, contract sterilization, laboratory testing, and operating room integration, with customers served across the Americas, Europe, and Asia.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueSingle-use products used in infection prevention, endoscopy, and sterile workflows.
Sterilizers, surgical tables, automated endoscope reprocessors, and OR integration systems.
Installation, maintenance, repair, and outsourced reprocessing services for medical facilities.
Contract sterilization, laboratory testing, and integrated sterilization systems for manufacturers.
Cleaning, sterilization, maintenance, and water systems for biopharma and medtech manufacturing.
Products
Reported · share of revenue- Products51.6 %
- Services48.4 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
STERIS sells to hospitals, ambulatory surgery centers, and other healthcare providers that need infection prevention, sterilization, and operating room workflow solutions. It also serves medical device and pharmaceutical manufacturers that outsource sterilization, testing, and validation services, plus biopharmaceutical and life sciences facilities that require aseptic manufacturing support. Customer relationships are often driven by regulatory compliance, clinical workflow reliability, and the need to maintain sterile environments and equipment uptime.
Hospitals and surgical facilities buy consumables, capital equipment, and service contracts to support infection prevention and sterile processing.
They use AST sterilization, testing, and process validation services to prepare sterile single-use products for market.
They outsource sterilization and testing services and buy equipment used in sterile production environments.
They purchase detergents, sterilizers, washers, decontamination systems, and maintenance services for aseptic operations.
They buy integrated sterilization equipment and related systems for controlled laboratory and development settings.
Strategy
STERIS focuses on innovation in infection prevention, sterile processing, and aseptic manufacturing support, combining consumables, equipment, and recurring services. It also uses acquisitions and a global service network to broaden its installed base, deepen customer relationships, and expand technical capabilities. Training, quality systems, and customer support are important because the business depends on compliance, reliability, and long equipment lifecycles.
Recurring revenue improves customer stickiness and supports installed-base monetization.
Proximity to manufacturing customers is critical for validation, capacity, and turnaround time.
Clinical and regulatory requirements make technical differentiation and adoption support important.
Acquisitions can add technologies, customers, and geographic reach, but require integration discipline.
Geography
2026STERIS operates globally, with facilities and sales activity across the Americas, Europe, and Asia. Its AST network is positioned near clusters of medical device and pharmaceutical manufacturing, while healthcare and life sciences products are sold to customers in many countries worldwide. This broad footprint reduces dependence on any single market but exposes the company to currency, trade, and regulatory differences across regions.
Share of the revenue the company reports by geography.
Risks
STERIS faces integration risk from acquisitions, since combining operations, controls, and customer relationships can be complex and costly. Its business is also exposed to regulation, litigation, international trade, currency swings, and competitive pricing pressure because many products and services are used in regulated healthcare and manufacturing environments. Demand can be affected by hospital spending, manufacturing activity, and the timing of customer orders and capital purchases.
- Acquisition integration failureImpact: HighLikelihood: Medium
The company has grown through acquisitions, and integration issues can reduce synergies and create operational disruption.
Exposure - Regulatory and litigation exposureImpact: HighLikelihood: Medium
Products and sterilization services operate in highly regulated environments, and litigation such as ethylene oxide matters can create costs or restrictions.
Exposure: AST and Healthcare
- Foreign exchange and international unrestImpact: MediumLikelihood: Medium
The company sells globally and reports across multiple regions, so currency moves and geopolitical disruption can affect results.
Exposure - Competitive pricing pressureImpact: MediumLikelihood: Medium
STERIS competes with large diversified healthcare and sterilization companies as well as niche specialists.
Exposure - Customer spending and order timingImpact: MediumLikelihood: Low
Capital equipment and outsourced services depend on customer budgets, project timing, and manufacturing activity.
Exposure: Healthcare capital equipment and AST
Accounting
Judgemental itemsAcquisitions create goodwill and intangible assets that require annual impairment testing and amortization judgments.
Impact: Can materially affect earnings if assumptions change
Fair value allocation to acquired assets and liabilities influences future amortization and reported profitability.
Impact: Affects post-deal earnings and balance sheet values
Consumables, services, equipment, and contract sterilization may be recognized differently depending on delivery and performance obligations.
Impact: Can shift quarterly revenue and margin mix
Regulatory and legal matters, including ethylene oxide litigation, may require provisions or disclosures.
Impact: Can create earnings volatility and cash outflows
Similar listed companies
Publicly listed companies with a comparable business focus.
Mesa Laboratories, Inc
MLAB · Industrial Instruments For Measurement, Display, and Control
Mesa Laboratories designs and manufactures life sciences tools and critical quality control solutions used in regulated pharmaceutical, healthcare, and medical device applications.
Entegris, Inc
ENTG · Plastics Products, NEC
Entegris makes advanced materials and process solutions used in semiconductor manufacturing, where ultra-high purity and contamination control are critical.
Thermo Fisher Scientific Inc
TMO · Measuring & Controlling Devices, NEC
Thermo Fisher Scientific is a U.S.-based life sciences and laboratory company organized around four segments: Life Sciences Solutions, Analytical Instruments,…
TOMI Environmental Solutions, Inc.
TOMZ · Industrial Organic Chemicals
Baxter International Inc
BAX · Surgical & Medical Instruments & Apparatus
Tenaris S.A
TS · Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens)
Last updated: 24/09/2026